ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,410, issued on June 23, was assigned to C4 Therapeutlcs Inc. (Watertown, Mass.).

"Compounds for targeted degradation of RET" was invented by James A. Henderson (Weston, Mass.), Christopher G. Nasveschuk (Stoneham, Mass.), Kiel Lazarski (Boston), Victoria Garza (San Antonio), Moses Moustakim (Brighton, Mass.), Jae Young Ahn (Somerville, Mass.), Gesine Kerstin Veits (Somerville, Mass.), Morgan Welzel O'Shea (Walthan, Mass.), Ryan E. Michael (Erie, Colo.), Jeremy L. Yap (Sudbury, Mass.), Yanke Liang (Belmont, Mass.), Andrew Charles Good (Watertown, Miss.), Mark E. Fitzgerald (Newton, Mass.) and Robert T. Yu (Arlington, Va.).

According to the abstract* released by the U.S. Patent & T...